Gene · 3357
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The selectivity implications of docking libraries with greater and lesser similarities to bio-like molecules. | bioRxiv | 2026 | 41676518 | PubTator, text mining | PubMed |
| Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease. | Pharmacopsychiatry | 2026 | 41643722 | PubTator, text mining | PubMed |
| Development and Validation of an LC-MS/MS Method for the Quantitative Estimation of Bexicaserin in Human Cerebrospinal Fluid. | Biomed Chromatogr | 2026 | 41635160 | PubTator, text mining | PubMed |
| Ondansetron reduces seizures and improves cognitive impairment in a rat model of temporal lobe epilepsy. | IBRO Neurosci Rep | 2026 | 41550980 | PubTator, text mining | PubMed |
| Intestinal Sclerostin Deficiency Links Gut Dysbiosis to Altered Serotonin Homeostasis in Axial Spondyloarthritis. | Inflammation | 2026 | 41518441 | PubTator, text mining | PubMed |
| Repositioning serotonergic antagonists as therapeutic agents in gastric cancer: induction of apoptosis, inhibition of cell migration, and cell cycle arrest in AGS cells. | Cytotechnology | 2026 | 41477555 | PubTator, text mining | PubMed |
| Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms. | Pharmacol Res | 2026 | 41475502 | PubTator, text mining | PubMed |
| Serotonin inhibits the influx of iron into cells by decreasing the expression of SLC11A2 in Caco-2 cells. | Biomed Rep | 2026 | 41356391 | PubTator, text mining | PubMed |
| A bibliometric study of the most-cited research articles and reviews in Naunyn-Schmiedeberg's Archives of Pharmacology (1969-2024). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40748476 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation. | Psychedelics (N Y) | 2025 | 42440716 | PubTator, text mining | PubMed |
| Across preclinical and clinical platforms, approved and investigational psychiatric drugs share pathways and associate with similar molecular functions. | Front Drug Discov (Lausanne) | 2025 | 42239657 | PubTator, text mining | PubMed |
| Immuno-neural mechanisms in gastrointestinal tumorigenesis: bridging inflammation, neural regulation, and therapeutic innovation. | Front Immunol | 2025 | 41799687 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy. | ACS Med Chem Lett | 2025 | 41256989 | PubTator, text mining | PubMed |
| Integrated bioinformatics and Toxicogenomics reveal bisphenol A-driven molecular networks and prognostic biomarkers in endometrial cancer. | Toxicol Res (Camb) | 2025 | 41220614 | PubTator, text mining | PubMed |
| Brain-Bone Axis in Physiological and Pathological Conditions. | Int J Mol Sci | 2025 | 41097093 | PubTator, text mining | PubMed |
| The aggressive colorectal cancer subtype marker HTR2B has a dual role depending on the tumor microenvironment. | Cell Commun Signal | 2025 | 41034989 | PubTator, text mining | PubMed |
| Blockade of PAR2 Signaling by Punicalagin as a Therapeutic Strategy for Atopic Dermatitis. | Int J Mol Sci | 2025 | 41009488 | PubTator, text mining | PubMed |
| Evaluating the Effects of Selective Serotonin Reuptake Inhibitors on Osteogenesis of Periodontal Stem Cells: An In Vitro Study. | Int Dent J | 2025 | 40961628 | PubTator, text mining | PubMed |
| The role of 5-HT2B-serotonin receptor in the modulatory effect of fluoxetine on interaction of macrophages with CD4+ T-cells in multiple sclerosis. | Int Immunopharmacol | 2025 | 40939435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3357/papers?page=3